ROSSI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 1.243
EU - Europa 813
AS - Asia 242
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.306
Nazione #
US - Stati Uniti d'America 1.239
IE - Irlanda 338
CN - Cina 124
DE - Germania 120
IT - Italia 106
SE - Svezia 71
TR - Turchia 56
SG - Singapore 49
UA - Ucraina 42
GB - Regno Unito 37
CZ - Repubblica Ceca 18
FI - Finlandia 18
FR - Francia 18
BE - Belgio 13
IN - India 9
RO - Romania 5
CH - Svizzera 3
DK - Danimarca 3
MD - Moldavia 3
PL - Polonia 3
PT - Portogallo 3
BD - Bangladesh 2
CA - Canada 2
ES - Italia 2
LU - Lussemburgo 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
CL - Cile 1
EC - Ecuador 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 2.306
Città #
Chandler 361
Dublin 338
Jacksonville 165
Boardman 82
Bremen 47
Lawrence 47
Princeton 47
L'aquila 44
New York 40
Ann Arbor 38
Nanjing 37
Singapore 35
Izmir 33
Ashburn 32
Munich 28
San Mateo 22
Wilmington 19
Brno 17
Beijing 13
Brussels 13
Woodbridge 10
L’Aquila 9
Nanchang 9
Seattle 9
Cambridge 8
Los Angeles 8
Des Moines 7
Hebei 7
Mountain View 7
Helsinki 6
Milan 6
Verona 6
Dallas 5
Fremont 5
Dearborn 4
Jiaxing 4
Norwalk 4
Stockholm 4
Chisinau 3
Copenhagen 3
Hangzhou 3
Houston 3
Jinan 3
Pescara 3
Pune 3
Tianjin 3
Berlin 2
Bolton 2
Braga 2
Cepagatti 2
Changsha 2
Chieti 2
Genova 2
Lanzhou 2
London 2
Madrid 2
Mentana 2
Ningbo 2
Saint Paul 2
Shanghai 2
Venezia 2
Vittuone 2
Warsaw 2
Washington 2
Zhengzhou 2
Adliswil 1
Alanno 1
Albuquerque 1
Andover 1
Atlanta 1
Avezzano 1
Belgrade 1
Bologna 1
Budapest 1
Capannori 1
Changchun 1
Chicago 1
Chittagong 1
Clifton 1
Cormeilles-en-Parisis 1
Cupertino 1
Duncan 1
Düsseldorf 1
Edinburgh 1
Florence 1
Fuzhou 1
Gainesville 1
Gold Hill 1
Groningen 1
Guangzhou 1
Hanover 1
Hefei 1
Johannesburg 1
Kunming 1
Lagos 1
Lappeenranta 1
Las Vegas 1
Laurens 1
Lisbon 1
Lucca 1
Totale 1.673
Nome #
Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not. 132
The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT) 92
The atypical antipsychotic clozapine selectively inhibits interleukin 8 (IL-8)-induced neutrophil chemotaxis. 89
Distinctive binding properties of the negative allosteric modulator, [3H]SB269,652, at recombinant dopamine D3receptors 84
The tetrahydroisoquinoline derivative SB269,652 is an allosteric antagonist at dopamine D3 and D2 receptors. 79
Variants of G protein-coupled receptors: a reappraisal of their role in receptor regulation 74
Dopamine D2receptors dimers: How can we pharmacologically target them? 73
Dichlorodiphenyltrichloroethane, an old pesticide with a new mechanism of toxicity 71
Neurotoxic and Neuroprotective Role of Exosomes in Parkinson's Disease 71
THE THYROID DISRUPTOR 1,1,1-TRICHLORO-2,2-BIS(P-CHLOROPHENYL)ETHANE (DDT) PREVENTS INTERNALIZATION OF THE TSH RECEPTOR 68
Historical Perspectives: From Monomers to Dimers and Beyond, an Exciting Journey in the World of G Protein-Coupled Receptors 67
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 67
The insecticide 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) alters the membrane raft location of the TSH receptor stably expressed in Chinese hamster ovary cells. 65
Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D(1)/D(2)/D(3) receptors vs D(2)/D(3) receptors only: parallel observations from co-transfected human and native cerebral receptors. 64
The First Negative Allosteric Modulator for Dopamine D2and D3Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs 64
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation 62
Dichlorodiphenyltrichloroethane (DDT) induced extracellular vesicle formation: a potential role in organochlorine increased risk of Parkinson's disease 59
The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor 56
Heterodimerization of dopamine receptors: new insights into functional and therapeutic significance. 56
Parkinson's disease and light: The bright and the Dark sides 52
A New Threat to Dopamine Neurons: The Downside of Artificial Light 51
Allosteric modulators of g protein-coupled dopamine and serotonin receptors: A new class of atypical antipsychotics 49
Presence of a putative steroidal allosteric site on glycoprotein hormone receptors 47
Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers 43
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs 38
-Arrestins as Important Regulators of Glucose and Energy Homeostasis 36
Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease 35
Allosteric modulation of β-cell M 3 muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice 35
Host tissue proteomics reveal insights into the molecular basis of Schistosoma haematobium-induced bladder pathology 32
Is adult hippocampal neurogenesis really relevant for the treatment of psychiatric disorders? 31
Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells 31
Gs-DREADD knock-in mice for tissuespecific, temporal stimulation of cyclic AMP signaling 31
Peptides derived from the sars-cov-2 receptor binding motif bind to ace2 but do not block ace2-mediated host cell entry or pro-inflammatory cytokine induction 31
Virus-Mediated Expression of DREADDs for In Vivo Metabolic Studies 30
Beta-cell M 3 muscarinic acetylcholine receptors as potential targets for novel antidiabetic drugs 30
Central IGF1 improves glucose tolerance and insulin sensitivity in mice 29
A G protein-biased designer G protein-coupled receptor useful for studying the physiological relevance of Gq/11-dependent signaling pathways 27
Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging 25
CK2 acts as a potent negative regulator of receptormediated insulin release in vitro and in vivo 25
Regulation
 of
 M3
 muscarinic
 receptor
 expression
 and
 function
 by
 transmembrane
 protein
 147 25
Spinophilin as a novel regulator of M3 muscarinic receptor-mediated insulin release in vitro and in vivo 25
Apolipoprotein B is a new target of the GDNF/RET and ET-3/EDNRB signalling pathways 24
β-Arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions 23
Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs 23
Hepatic β-arrestin 2 is essential for maintaining euglycemia 22
GPCRs in Intracellular Compartments: New Targets for Drug Discovery 22
β-Arrestin-1 is required for adaptive β-cell mass expansion during obesity 20
Muscarinic receptors as model targets and antitargets for structure-based ligand discovery 18
Hepatic Gi signaling regulates whole-body glucose homeostasis 18
The C-terminus of the prototypical M2 muscarinic receptor localizes to the mitochondria and regulates cell respiration under stress conditions 15
M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease 11
In-vitro approaches to investigate the detrimental effect of light on dopaminergic neurons 10
Unraveling the Functional Significance of Unstructured Regions in G Protein-Coupled Receptors 8
β-Cell-intrinsic β-arrestin 1 signaling enhances sulfonylurea-induced insulin secretion 7
Totale 2.372
Categoria #
all - tutte 12.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020154 0 0 24 1 5 33 33 1 22 9 3 23
2020/2021203 3 24 8 22 23 7 25 9 22 8 45 7
2021/2022219 7 7 37 8 1 3 2 29 19 2 11 93
2022/20231.069 59 69 10 126 102 112 0 86 445 3 41 16
2023/2024235 38 4 9 13 27 62 4 10 1 7 26 34
2024/2025143 39 23 81 0 0 0 0 0 0 0 0 0
Totale 2.372